Biophytis S.A. (BPTSY)
OTCMKTS · Delayed Price · Currency is USD
1.380
-0.620 (-31.00%)
Sep 11, 2025, 8:00 PM EDT
Biophytis Market Cap
Biophytis has a market cap or net worth of $4.74 million as of September 15, 2025. Its market cap has increased by 53.72% in one year.
Market Cap
4.74M
Enterprise Value
16.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.38
Market Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 49.80M to 4.74M, a decrease of -90.48%. That is a compound annual growth rate of -20.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 4.74M | 64.40% |
| Dec 31, 2024 | 2.88M | -28.25% |
| Dec 29, 2023 | 4.02M | -50.09% |
| Dec 30, 2022 | 8.05M | -88.62% |
| Dec 31, 2021 | 70.76M | -37.02% |
| Dec 31, 2020 | 112.35M | 3,661.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |